An AllTrials project

NCT03046238: An overdue trial by South Egypt Cancer Institute

This trial is overdue. It was due to report 7 years ago.

Think we've made a mistake? Before contacting us, review the criteria in our paper. In particular, bear in mind the following:

  • We can only rely on the structured data that sponsors put into the registry: they may enter incorrect or incomplete data.
  • Reporting in a journal is not enough. The FDAAA rules state that the trial must be reported on ClinicalTrials.gov.
  • Terminated trials are required to report results. Only withdrawn trials (which never recruited a single patient) are not.

Full data

Full entry on ClinicalTrials.gov NCT03046238
Title Efficacy and Safety of Dexmedetomidine Added to Modified Pectoral's Block in Patient Undergoing Breast Cancer Surgery :A Comparative Study
Results Status Overdue
ACT or pACT? This is what FDAAA officially calls an "Applicable Clinical Trial"
Start date Feb. 2, 2017
Completion date April 2, 2017
Required reporting date April 2, 2018, midnight
Actual reporting date None
Date last checked at ClinicalTrials.gov April 2, 2025
Days late 2557